Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Curcumin may be an effective and safer anticancer agent by regulating key cell pathways.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

A man developed skin issues from cancer medication, which improved with specific treatments.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Understanding breast cancer requires considering both medical advancements and social influences.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Some breast cancer chemotherapy can cause permanent hair loss.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

High-dose vitamin A was safe and well-tolerated in a lung cancer treatment study.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.